120 related articles for article (PubMed ID: 9091511)
1. A physiologically based pharmacokinetic model for retinoic acid and its metabolites.
Clewell HJ; Andersen ME; Wills RJ; Latriano L
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S77-85. PubMed ID: 9091511
[TBL] [Abstract][Full Text] [Related]
2. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
Tzimas G; Thiel R; Chahoud I; Nau H
Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
[TBL] [Abstract][Full Text] [Related]
3. The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use.
Latriano L; Tzimas G; Wong F; Wills RJ
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S37-46. PubMed ID: 9091507
[TBL] [Abstract][Full Text] [Related]
4. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
5. Are topical retinoids teratogenic?
Veraldi S; Rossi LC; Barbareschi M
G Ital Dermatol Venereol; 2016 Dec; 151(6):700-705. PubMed ID: 27598619
[TBL] [Abstract][Full Text] [Related]
6. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
7. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
8. A risk assessment of topical tretinoin as a potential human developmental toxin based on animal and comparative human data.
Johnson EM
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S86-90. PubMed ID: 9091512
[TBL] [Abstract][Full Text] [Related]
9. Comparative distribution, pharmacokinetics and placental permeabilities of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-4-oxo-retinoic acid, retinyl acetate and 9-cis-retinal in hamsters.
Howard WB; Willhite CC; Omaye ST; Sharma RP
Arch Toxicol; 1989; 63(2):112-20. PubMed ID: 2730336
[TBL] [Abstract][Full Text] [Related]
10. A developmental toxicity study of tretinoin emollient cream (Renova) applied topically to New Zealand white rabbits.
Christian MS; Mitala JJ; Powers WJ; McKenzie BE; Latriano L
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S67-76. PubMed ID: 9091510
[TBL] [Abstract][Full Text] [Related]
11. Tretinoin: a review of the nonclinical developmental toxicology experience.
Kochhar DM; Christian MS
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S47-59. PubMed ID: 9091508
[TBL] [Abstract][Full Text] [Related]
12. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
Löfberg B; Chahoud I; Bochert G; Nau H
Teratology; 1990 Jun; 41(6):707-16. PubMed ID: 2141193
[TBL] [Abstract][Full Text] [Related]
13. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice.
Creech Kraft J; Löfberg B; Chahoud I; Bochert G; Nau H
Toxicol Appl Pharmacol; 1989 Aug; 100(1):162-76. PubMed ID: 2763297
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of retinoids in women after meal consumption or vitamin A supplementation.
Chen C; Mistry G; Jensen B; Heizmann P; Timm U; van Brummelen P; Rakhit AK
J Clin Pharmacol; 1996 Sep; 36(9):799-808. PubMed ID: 8889900
[TBL] [Abstract][Full Text] [Related]
15. Embryotoxicity and teratogenicity of topical retinoic acid.
Nau H
Skin Pharmacol; 1993; 6 Suppl 1():35-44. PubMed ID: 8142110
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
17. Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization.
Rühl R; Plum C; Elmazar MM; Nau H
Toxicol Sci; 2001 Sep; 63(1):82-9. PubMed ID: 11509747
[TBL] [Abstract][Full Text] [Related]
18. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
Willhite CC; Lovey A; Eckhoff C
Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
